<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-02383831</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-02T22:23:58+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Is There Any Room for Pharmacometrics With Immuno-Oncology Drugs? Input from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology</title>
            <author role="aut">
              <persName>
                <forename type="first">Anne</forename>
                <surname>Rodallec</surname>
              </persName>
              <email type="md5">296e6d1ad58c9cdd0ee9efbf0fb1ffcb</email>
              <email type="domain">univ-amu.fr</email>
              <idno type="idhal" notation="string">anne-rodallec</idno>
              <idno type="idhal" notation="numeric">751465</idno>
              <idno type="halauthorid" notation="string">40682-751465</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-0787-8241</idno>
              <affiliation ref="#struct-537143"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Raphaelle</forename>
                <surname>Fanciullino</surname>
              </persName>
              <email type="md5">7c11f7a6e9cfe09448549b3206173c31</email>
              <email type="domain">univ-amu.fr</email>
              <idno type="idhal" notation="string">raphaelle-fanciullino</idno>
              <idno type="idhal" notation="numeric">751464</idno>
              <idno type="halauthorid" notation="string">1025486-751464</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-6750-4658</idno>
              <idno type="IDREF">https://www.idref.fr/10300369X</idno>
              <idno type="VIAF">https://viaf.org/viaf/212011421</idno>
              <idno type="ISNI">http://isni.org/isni/0000000358679370</idno>
              <affiliation ref="#struct-537143"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Sébastien</forename>
                <surname>Benzekry</surname>
              </persName>
              <email type="md5">058c3fc27bb7f758cba0c0195d61a833</email>
              <email type="domain">phare.normalesup.org</email>
              <idno type="idhal" notation="string">sebastien-benzekry</idno>
              <idno type="idhal" notation="numeric">12116</idno>
              <idno type="halauthorid" notation="string">9370-12116</idno>
              <idno type="ARXIV">https://arxiv.org/a/benzekry_s_1</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-3749-8637</idno>
              <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=xsLpdFAAAAAJ&amp;hl=fr&amp;oi=ao</idno>
              <idno type="IDREF">https://www.idref.fr/159344212</idno>
              <affiliation ref="#struct-409748"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Joseph</forename>
                <surname>Ciccolini</surname>
              </persName>
              <email type="md5">3714cb9f0d63a327527e73a74ca9ec63</email>
              <email type="domain">univmed.fr</email>
              <idno type="idhal" notation="numeric">1211831</idno>
              <idno type="halauthorid" notation="string">518104-1211831</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-1733-3410</idno>
              <idno type="IDREF">https://www.idref.fr/060250402</idno>
              <idno type="VIAF">https://viaf.org/viaf/190557753</idno>
              <idno type="ISNI">http://isni.org/isni/0000000138750155</idno>
              <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=1ww58o0AAAAJ</idno>
              <affiliation ref="#struct-537143"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Sebastien</forename>
                <surname>Benzekry</surname>
              </persName>
              <email type="md5">6265406c2f4b74e0106bf0ba27675c40</email>
              <email type="domain">inria.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2019-12-09 11:26:40</date>
              <date type="whenModified">2025-03-18 03:15:50</date>
              <date type="whenReleased">2019-12-09 14:50:27</date>
              <date type="whenProduced">2019-07-01</date>
              <date type="whenEndEmbargoed">2019-12-31</date>
              <ref type="file" target="https://inria.hal.science/hal-02383831v1/document">
                <date notBefore="2019-12-31"/>
              </ref>
              <ref type="file" subtype="author" n="1" target="https://inria.hal.science/hal-02383831v1/file/2019_Rodallec_AnticancerResearch_Is%20There%20Any%20Room%20for%20Pharmacometrics%20With%20Immuno-Oncology%20Drugs%3F%20Input%20from%20the%20EORTC-PAMM%20Course%20on%20Preclinical%20and%20Early-phase%20Clinical%20Pharmacology.pdf" id="file-2383831-2292920">
                <date notBefore="2019-12-31"/>
              </ref>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="153845">
                <persName>
                  <forename>Sebastien</forename>
                  <surname>Benzekry</surname>
                </persName>
                <email type="md5">6265406c2f4b74e0106bf0ba27675c40</email>
                <email type="domain">inria.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-02383831</idno>
            <idno type="halUri">https://inria.hal.science/hal-02383831</idno>
            <idno type="halBibtex">rodallec:hal-02383831</idno>
            <idno type="halRefHtml">&lt;i&gt;Anticancer Research&lt;/i&gt;, 2019, 39 (7), pp.3419-3422. &lt;a target="_blank" href="https://dx.doi.org/10.21873/anticanres.13486"&gt;&amp;#x27E8;10.21873/anticanres.13486&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Anticancer Research, 2019, 39 (7), pp.3419-3422. &amp;#x27E8;10.21873/anticanres.13486&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://about.hal.science/hal-authorisation-v1/">HAL Authorization<ref corresp="#file-2383831-2292920"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="INRIA">INRIA - Institut National de Recherche en Informatique et en Automatique</idno>
            <idno type="stamp" n="UNIV-AMU">Aix Marseille Université</idno>
            <idno type="stamp" n="IMB">Institut de Mathématiques de Bordeaux</idno>
            <idno type="stamp" n="INRIA-BORDEAUX">INRIA Bordeaux - Sud-Ouest</idno>
            <idno type="stamp" n="INSMI">CNRS-INSMI - INstitut des Sciences Mathématiques et de leurs Interactions</idno>
            <idno type="stamp" n="SANTE_PUB_INSERM" corresp="INSERM">Santé Publique à l'Inserm</idno>
            <idno type="stamp" n="INRIA_TEST">INRIA - Institut National de Recherche en Informatique et en Automatique</idno>
            <idno type="stamp" n="TESTALAIN1">TESTALAIN1</idno>
            <idno type="stamp" n="INRIA2">INRIA 2</idno>
            <idno type="stamp" n="TDS-MACS">Réseau de recherche en Théorie des Systèmes Distribués, Modélisation, Analyse et Contrôle des Systèmes</idno>
            <idno type="stamp" n="CRCM">Centre de Recherche en Cancérologie de Marseille</idno>
            <idno type="stamp" n="TEST-HALCNRS">Collection test HAL CNRS</idno>
            <idno type="stamp" n="INRIAARTDOI">INRIAARTDOI</idno>
            <idno type="stamp" n="UNIVERSITE-BORDEAUX">Université de Bordeaux</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Is There Any Room for Pharmacometrics With Immuno-Oncology Drugs? Input from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Anne</forename>
                    <surname>Rodallec</surname>
                  </persName>
                  <email type="md5">296e6d1ad58c9cdd0ee9efbf0fb1ffcb</email>
                  <email type="domain">univ-amu.fr</email>
                  <idno type="idhal" notation="string">anne-rodallec</idno>
                  <idno type="idhal" notation="numeric">751465</idno>
                  <idno type="halauthorid" notation="string">40682-751465</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-0787-8241</idno>
                  <affiliation ref="#struct-537143"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Raphaelle</forename>
                    <surname>Fanciullino</surname>
                  </persName>
                  <email type="md5">7c11f7a6e9cfe09448549b3206173c31</email>
                  <email type="domain">univ-amu.fr</email>
                  <idno type="idhal" notation="string">raphaelle-fanciullino</idno>
                  <idno type="idhal" notation="numeric">751464</idno>
                  <idno type="halauthorid" notation="string">1025486-751464</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-6750-4658</idno>
                  <idno type="IDREF">https://www.idref.fr/10300369X</idno>
                  <idno type="VIAF">https://viaf.org/viaf/212011421</idno>
                  <idno type="ISNI">http://isni.org/isni/0000000358679370</idno>
                  <affiliation ref="#struct-537143"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Sébastien</forename>
                    <surname>Benzekry</surname>
                  </persName>
                  <email type="md5">058c3fc27bb7f758cba0c0195d61a833</email>
                  <email type="domain">phare.normalesup.org</email>
                  <idno type="idhal" notation="string">sebastien-benzekry</idno>
                  <idno type="idhal" notation="numeric">12116</idno>
                  <idno type="halauthorid" notation="string">9370-12116</idno>
                  <idno type="ARXIV">https://arxiv.org/a/benzekry_s_1</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-3749-8637</idno>
                  <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=xsLpdFAAAAAJ&amp;hl=fr&amp;oi=ao</idno>
                  <idno type="IDREF">https://www.idref.fr/159344212</idno>
                  <affiliation ref="#struct-409748"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Joseph</forename>
                    <surname>Ciccolini</surname>
                  </persName>
                  <email type="md5">3714cb9f0d63a327527e73a74ca9ec63</email>
                  <email type="domain">univmed.fr</email>
                  <idno type="idhal" notation="numeric">1211831</idno>
                  <idno type="halauthorid" notation="string">518104-1211831</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-1733-3410</idno>
                  <idno type="IDREF">https://www.idref.fr/060250402</idno>
                  <idno type="VIAF">https://viaf.org/viaf/190557753</idno>
                  <idno type="ISNI">http://isni.org/isni/0000000138750155</idno>
                  <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=1ww58o0AAAAJ</idno>
                  <affiliation ref="#struct-537143"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">22686</idno>
                <idno type="issn">0250-7005</idno>
                <title level="j">Anticancer Research</title>
                <imprint>
                  <publisher>International Institute of Anticancer Research</publisher>
                  <biblScope unit="volume">39</biblScope>
                  <biblScope unit="issue">7</biblScope>
                  <biblScope unit="pp">3419-3422</biblScope>
                  <date type="datePub">2019-07-01</date>
                </imprint>
              </monogr>
              <idno type="doi">10.21873/anticanres.13486</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">Combinatorial strategies</term>
                <term xml:lang="en">Review</term>
                <term xml:lang="en">PK/PD</term>
                <term xml:lang="en">Pharmacometrics</term>
                <term xml:lang="en">Immuno-oncology drugs</term>
              </keywords>
              <classCode scheme="halDomain" n="info.info-mo">Computer Science [cs]/Modeling and Simulation</classCode>
              <classCode scheme="halDomain" n="sdv.can">Life Sciences [q-bio]/Cancer</classCode>
              <classCode scheme="halDomain" n="phys.phys.phys-data-an">Physics [physics]/Physics [physics]/Data Analysis, Statistics and Probability [physics.data-an]</classCode>
              <classCode scheme="halDomain" n="sdv.spee">Life Sciences [q-bio]/Santé publique et épidémiologie</classCode>
              <classCode scheme="halDomain" n="sdv.sp.pharma">Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology</classCode>
              <classCode scheme="halDomain" n="stat.ap">Statistics [stat]/Applications [stat.AP]</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>As part of the Pharmacology &amp; Molecular Mechanisms (PAMM) Group, European Organization for Research and Treatment on Cancer (EORTC) 2019 winter Meeting Educational sessions, special focus has been placed on strategies to be undertaken to reduce the attrition rate when developing immune-oncology drugs. Immune checkpoint inhibitors have been game-changing drugs in several settings over the past decade such as melanoma and lung cancer. However, during the last years a rising number of studies failing to further improve clinical outcome in patients with cancer was recorded. Extensive pharmacometrics such as pharmacokinetics/ pharmacodynamics modeling support should help to overcome the current glass ceiling that has apparently been reached with immuno-oncology drugs (IOD). In particular, it should help in the issue of setting up combinatorial regimen (i.e. combining immune checkpoint inhibitors with cytotoxics, anti-angiogenesis or targeted therapies) that can no longer be addressed when following standard trial-and-error approaches, but rather by using mathematical-derived algorithms as decision-making tools by investigators for rational design. In routine clinical setting, developing therapeutic drug monitoring of immune checkpoint inhibitors with adaptive dosing strategies has been a long-neglected strategy. Still, substantial improvements might be achieved using dedicated tools for precision medicine and personalized medicine in immunotherapy.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="researchteam" xml:id="struct-537143" status="VALID">
          <orgName>Simulation and Modeling of Adaptive Response for Therapeutics in Cancer</orgName>
          <orgName type="acronym">SMARTc</orgName>
          <desc>
            <address>
              <addrLine>Faculté de Pharmacie de Marseille27 boulevard Jean Moulin13385 Marseille</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://crcm.marseille.inserm.fr/plateformestechnologiques/smartc/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-179570" type="direct"/>
            <relation name="UM105" active="#struct-198056" type="indirect"/>
            <relation name="UMR7258" active="#struct-301325" type="indirect"/>
            <relation active="#struct-301051" type="indirect"/>
            <relation name="U1068" active="#struct-303623" type="indirect"/>
            <relation name="UMR7258" active="#struct-441569" type="indirect"/>
          </listRelation>
        </org>
        <org type="researchteam" xml:id="struct-409748" status="VALID">
          <idno type="RNSR">201521155J</idno>
          <idno type="ROR">https://ror.org/02kxjkv05</idno>
          <orgName>Modélisation Mathématique pour l'Oncologie</orgName>
          <orgName type="acronym">MONC</orgName>
          <date type="start">2015-01-01</date>
          <date type="end">2027-12-31</date>
          <desc>
            <address>
              <addrLine>200, avenue de la Vieille Tour 33405 Talence cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inria.fr/equipes/monc</ref>
          </desc>
          <listRelation>
            <relation active="#struct-27730" type="direct"/>
            <relation active="#struct-259761" type="indirect"/>
            <relation active="#struct-409745" type="indirect"/>
            <relation name="UMR5251" active="#struct-441569" type="indirect"/>
            <relation active="#struct-28493" type="direct"/>
            <relation active="#struct-502406" type="indirect"/>
            <relation active="#struct-104751" type="direct"/>
            <relation active="#struct-300009" type="indirect"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-179570" status="VALID">
          <idno type="RNSR">201220152G</idno>
          <idno type="ROR">0494jpz02</idno>
          <orgName>Centre de Recherche en Cancérologie de Marseille</orgName>
          <orgName type="acronym">CRCM</orgName>
          <date type="start">2012</date>
          <desc>
            <address>
              <addrLine>27 bd Leï Roure, BP 30005913273 Marseille Cedex 09</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://crcm.marseille.inserm.fr/spip.php?article314</ref>
          </desc>
          <listRelation>
            <relation name="UM105" active="#struct-198056" type="direct"/>
            <relation name="UMR7258" active="#struct-301325" type="direct"/>
            <relation active="#struct-301051" type="indirect"/>
            <relation name="U1068" active="#struct-303623" type="direct"/>
            <relation name="UMR7258" active="#struct-441569" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-198056" status="VALID">
          <idno type="IdRef">15863621X</idno>
          <idno type="ISNI">0000 0001 2176 4817</idno>
          <idno type="ROR">https://ror.org/035xkbk20</idno>
          <orgName>Aix Marseille Université</orgName>
          <orgName type="acronym">AMU</orgName>
          <date type="start">2012-01-01</date>
          <desc>
            <address>
              <addrLine>Aix-Marseille UniversitéJardins du Pharo58 Boulevard Charles Livon13284 Marseille cedex 7</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-amu.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-301325" status="VALID">
          <idno type="ROR">https://ror.org/04s3t1g37</idno>
          <orgName>Institut Paoli-Calmettes</orgName>
          <orgName type="acronym">IPC</orgName>
          <desc>
            <address>
              <addrLine>232 Boulevard de Sainte-Marguerite13009 Marseille</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.institutpaolicalmettes.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-301051" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-301051" status="VALID">
          <orgName>Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-441569" status="VALID">
          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <idno type="ROR">https://ror.org/02feahw73</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cnrs.fr/</ref>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-27730" status="VALID">
          <idno type="IdRef">155051342</idno>
          <idno type="ISNI">0000000123024783</idno>
          <idno type="RNSR">200711916B</idno>
          <idno type="ROR">https://ror.org/05m3r1b84</idno>
          <orgName>Institut de Mathématiques de Bordeaux</orgName>
          <orgName type="acronym">IMB</orgName>
          <date type="start">2003-01-01</date>
          <desc>
            <address>
              <addrLine>351 cours de la Libération 33405 TALENCE CEDEX</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.math.u-bordeaux.fr/IMB/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-259761" type="direct"/>
            <relation active="#struct-409745" type="direct"/>
            <relation name="UMR5251" active="#struct-441569" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-259761" status="VALID">
          <idno type="IdRef">175206562</idno>
          <idno type="ROR">https://ror.org/057qpr032</idno>
          <orgName>Université de Bordeaux</orgName>
          <orgName type="acronym">UB</orgName>
          <desc>
            <address>
              <addrLine>35, place Pey Berland - 33076 Bordeaux</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.u-bordeaux.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-409745" status="VALID">
          <orgName>Institut Polytechnique de Bordeaux</orgName>
          <orgName type="acronym">Bordeaux INP</orgName>
          <desc>
            <address>
              <addrLine>Avenue des facultés33405 Talence</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.bordeaux-inp.fr/fr</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-28493" status="VALID">
          <idno type="ROR">https://ror.org/02yw1f353</idno>
          <orgName>Institut Bergonié [Bordeaux]</orgName>
          <desc>
            <address>
              <addrLine>229, cours de l'Argonne - 33076 Bordeaux</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.bergonie.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-502406" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-502406" status="VALID">
          <orgName>UNICANCER</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75654 Paris Cedex 13</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.unicancer.fr/</ref>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-104751" status="VALID">
          <idno type="RNSR">200818243Z</idno>
          <idno type="ROR">https://ror.org/03tjcj052</idno>
          <orgName>Centre Inria de l'Université de Bordeaux</orgName>
          <desc>
            <address>
              <addrLine>200, avenue de la Vieille Tour, 33405 Talence</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inria.fr/bordeaux/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300009" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300009" status="VALID">
          <idno type="ROR">https://ror.org/02kvxyf05</idno>
          <orgName>Institut National de Recherche en Informatique et en Automatique</orgName>
          <orgName type="acronym">Inria</orgName>
          <desc>
            <address>
              <addrLine>Domaine de VoluceauRocquencourt - BP 10578153 Le Chesnay Cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inria.fr/en/</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>